Fuji Pharma Co.,Ltd. Logo

Fuji Pharma Co.,Ltd.

Pharmaceutical firm focused on women's healthcare and contract manufacturing services.

4554 | T

Overview

Corporate Details

ISIN(s):
JP3816200004
LEI:
Country:
Japan
Address:
千代田区三番町5番地7

Description

Fuji Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription medical products. The company's primary focus is on women's healthcare, including hormonal preparations for obstetrics and gynecology, alongside curative medicines and in-vitro diagnostics. Its portfolio includes both specialty and generic drugs. In addition to developing its own pharmaceuticals, Fuji Pharma offers extensive contract manufacturing services for a wide variety of dosage forms, such as solids, injections, ointments, creams, and liquids, for domestic and international clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-05-09 02:10
四半期報告書-第58期第2四半期(令和4年1月1日-令和4年3月31日)
Japanese 188.5 KB
2022-02-07 02:04
四半期報告書-第58期第1四半期(令和3年10月1日-令和3年12月31日)
Japanese 155.3 KB
2021-12-20 01:26
内部統制報告書-第57期(令和2年10月1日-令和3年9月30日)
Japanese 21.9 KB
2021-12-20 01:25
有価証券報告書-第57期(令和2年10月1日-令和3年9月30日)
Japanese 921.4 KB
2021-12-20 01:25
確認書
Japanese 8.2 KB
2021-08-06 02:08
四半期報告書-第57期第3四半期(令和3年4月1日-令和3年6月30日)
Japanese 149.3 KB
2021-05-10 02:07
四半期報告書-第57期第2四半期(令和3年1月1日-令和3年3月31日)
Japanese 182.1 KB
2021-02-08 01:08
四半期報告書-第57期第1四半期(令和2年10月1日-令和2年12月31日)
Japanese 145.9 KB
2020-12-18 06:39
有価証券報告書-第56期(令和1年10月1日-令和2年9月30日)
Japanese 882.4 KB
2020-12-18 06:39
内部統制報告書-第56期(令和1年10月1日-令和2年9月30日)
Japanese 22.1 KB
2020-12-18 06:39
確認書
Japanese 8.0 KB
2020-08-07 02:27
四半期報告書-第56期第3四半期(令和2年4月1日-令和2年6月30日)
Japanese 139.0 KB
2020-05-11 02:04
四半期報告書-第56期第2四半期(令和2年1月1日-令和2年3月31日)
Japanese 173.0 KB
2020-02-07 01:05
四半期報告書-第56期第1四半期(令和1年10月1日-令和1年12月31日)
Japanese 135.6 KB
2019-12-19 03:26
有価証券報告書-第55期(平成30年10月1日-令和1年9月30日)
Japanese 849.6 KB

Automate Your Workflow. Get a real-time feed of all Fuji Pharma Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fuji Pharma Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fuji Pharma Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.